Semi-Annual Consolidated Balance Sheet

Mochida Pharmaceutical Co.,Ltd. - Filing #7714401

Concept As at
2018-12-31
As at
2018-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
46,106,000,000 JPY
45,683,000,000 JPY
Securities
7,999,000,000 JPY
7,999,000,000 JPY
Other
2,036,000,000 JPY
2,691,000,000 JPY
Current assets
114,852,000,000 JPY
113,151,000,000 JPY
Non-current assets
Property, plant and equipment
13,652,000,000 JPY
13,915,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
5,450,000,000 JPY
5,677,000,000 JPY
Machinery, equipment and vehicles
Machinery, equipment and vehicles, net
2,133,000,000 JPY
2,207,000,000 JPY
Land
5,290,000,000 JPY
5,256,000,000 JPY
Other
Other, net
777,000,000 JPY
774,000,000 JPY
Intangible assets
Intangible assets
390,000,000 JPY
365,000,000 JPY
Investments and other assets
28,885,000,000 JPY
27,614,000,000 JPY
Investments and other assets
Investment securities
19,577,000,000 JPY
17,597,000,000 JPY
Other
6,086,000,000 JPY
6,012,000,000 JPY
Non-current assets
42,927,000,000 JPY
41,895,000,000 JPY
Assets
157,780,000,000 JPY
155,047,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
10,565,000,000 JPY
13,430,000,000 JPY
Income taxes payable
1,048,000,000 JPY
1,233,000,000 JPY
Other
9,642,000,000 JPY
8,463,000,000 JPY
Current liabilities
24,798,000,000 JPY
29,574,000,000 JPY
Non-current liabilities
Retirement benefit liability
5,153,000,000 JPY
5,374,000,000 JPY
Other
404,000,000 JPY
412,000,000 JPY
Non-current liabilities
5,558,000,000 JPY
5,786,000,000 JPY
Liabilities
30,356,000,000 JPY
35,360,000,000 JPY
Provision for bonuses
1,283,000,000 JPY
2,499,000,000 JPY
Net assets
Shareholders' equity
Share capital
7,229,000,000 JPY
7,229,000,000 JPY
Capital surplus
1,871,000,000 JPY
1,871,000,000 JPY
Retained earnings
110,951,000,000 JPY
104,625,000,000 JPY
Treasury shares
-2,361,000,000 JPY
-2,349,000,000 JPY
Shareholders' equity
117,691,000,000 JPY
111,376,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
9,679,000,000 JPY
8,305,000,000 JPY
Remeasurements of defined benefit plans
52,000,000 JPY
4,000,000 JPY
Valuation and translation adjustments
9,732,000,000 JPY
8,310,000,000 JPY
Net assets
127,423,000,000 JPY
119,687,000,000 JPY
Liabilities and net assets
157,780,000,000 JPY
155,047,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.